Also de Queiroz et al. found that BCG, like TLR2, TLR4, and TLR9 agonists, could not trigger the secretion of proinflammatory cytokines from MB49 HLA-I– murine bladder carcinoma (25). Here, TLR9 is linked to urinary bladder carcinoma.